Domestic Policy Focus - The industry stabilization plans for steel, construction materials, and light industry have been issued, emphasizing capacity regulation compared to previous versions [3][6][8] - The steel industry plan aims for an average annual growth of around 4% in value added, with a focus on supply-side structural adjustments and strict capacity control measures [9][10] - The construction materials plan prohibits the addition of new cement and flat glass capacity, requiring capacity replacement plans for new and renovated projects [10][11] Biopharmaceutical Sector - The National Drug Procurement Office released the national centralized drug procurement document (GY-YD2025-1), focusing on optimizing procurement rules and reducing drug costs for the public [18] - Changes in the procurement process include stricter qualification standards for bidding companies and modifications to the selection rules to respect clinical choices [18] Overseas Policy Developments - The U.S. Congress delegation visited China, with discussions focusing on Taiwan and military issues [3][6] - The U.S. and U.K. signed a significant technology cooperation agreement during President Trump's visit, addressing core issues such as the Israel-Palestine conflict and the Russia-Ukraine situation [3][6] Weekly Industry Policy Review - Key areas of focus include the rectification of internal competition, new production capabilities, infrastructure, new energy vehicles, media, and biopharmaceuticals [3][6] Other Policies - The third round of inspections by various financial regulatory bodies has been reported, indicating ongoing efforts to improve regulatory compliance and governance [3][6]
国内外产业政策周报:钢铁建材等稳增长方案陆续印发,美国众议院代表团访华-20250927
CMS·2025-09-27 08:34